Monday June 26th 2017

Archive for June, 2013

Mum diagnosed with multiple sclerosis discovers it was really parasitic tick bite

Mum diagnosed with multiple sclerosis discovers it was really parasitic tick bite

A mum treated for multiple sclerosis for two years was actually infected with a parasitic tick bite and cured herself with antibiotics. Julia Marshall-Wessendorf, 37, was ­diagnosed with the potentially crippling disease after visiting her GP with a numb finger. The [Read More]

Woodlands man hopes to sting away effects of multiple sclerosis

Woodlands man hopes to sting away effects of multiple sclerosis

The fatigue from Alan Swor’s multiple sclerosis was so bad that he had to stop and rest while brushing his teeth or while shaving. However, the 48-year-old resident of The Woodlands is feeling much better and the fatigue is almost gone since starting a treatment regimen [Read More]

Multiple Sclerosis: ‘I’ll never let my illness hold me back’

Multiple Sclerosis: ‘I’ll never let my illness hold me back’

Samantha McCarthy likes nothing better than taking to the country roads on her bicycle of a summer evening – but this Clarewoman is not your typical cyclist. The petite blonde, who took up cycling two years ago, has spent the last two months preparing for the formidable [Read More]

 Page 1 of 2  1  2 »

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]